Osteoarthritis Trial, Recruiting NCT07465484 Sponsor: I.M. Sechenov First Moscow State Medical University Condition: Osteoarthritis
Back to Osteoarthritis

Osteoarthritis Trial, Recruiting

NCT07465484
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults aged 18 or older who have been diagnosed with moderate to severe knee osteoarthritis (grade 3 or 4 on a standard medical scale) and report a pain level of 5 or higher out of 10.
  • People whose leg alignment shows an inward bowing of the knee beyond a certain angle (sometimes called "varus" or "bow-legged" alignment), as measured by their doctor.
  • People whose overall health means they can safely undergo anaesthesia, up to a moderate risk level on a standard medical scale (ASA grade III or below).
  • People with a body mass index (BMI) below 35 kg/m².
  • People who are able to attend all follow-up appointments over the full 12-month study period.
  • People who are mentally able to understand and follow the study requirements.
  • People who are willing to provide written consent to take part in the study.

Who may not be able to join:

  • People with a BMI above 40 kg/m².
  • People whose knee ligaments are unstable in a way that would require additional ligament support devices, or who have significant bone loss in the knee area.
  • People who have difficulty bearing weight on their other (opposite) leg.
  • People who have metal implants or foreign objects in either of their lower limbs.
  • People who have previously had knee surgery such as ligament reconstruction or bone-correction surgery on the thigh or shin bone.
  • People who do not wish to take part in the study.
  • People who are unlikely to follow their treating doctor's instructions or the required study schedule.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
I.M. Sechenov First Moscow State Medical University
Registry
ClinicalTrials.gov
Start date
1 September 2024
Est. completion
31 August 2027

Where this trial is recruiting

🇷🇺 Russia

Primary endpoints

Implant position assessment; Implant position assessment; Implant position assessment

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov